Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.
BACKGROUND
Hyperuricemia has been associated with the development of hypertension, cardiovascular, and renal disease. However, there is no data about the effect of lowering uric acid level on hypertension, renal function, and proteinuria in patients with glomerular filtration rate (GFR) >60 ml/min. We therefore conducted a prospective study to investigate the benefits of allopurinol treatment in hyperuricemic patients with normal renal function.


METHODS
Forty-eight hyperuricemic and 21 normouricemic patients were included in the study. Hyperuricemic patients received 300 mg/day allopurinol for three months. All patients' serum creatinine level, 24-h urine protein level, glomerular filtration rate, and blood pressure levels were measured at baseline and after three months of treatment.


RESULTS
A total of 59 patients completed the three-month follow-up period of observation. In the allopurinol group, serum uric acid levels, GFR, systolic and diastolic blood pressure, and C-reactive protein (CRP) levels significantly improved (P < 0.05). However, urine protein excretion remained unchanged (P > 0.05). No correlation was observed between changes in GFR and changes in CRP, or blood pressure in the allopurinol group. No significant changes were observed in the control group (P > 0.05).


CONCLUSIONS
We bring indirect evidence that hyperuricemia increases blood pressure, and decreases GFR. Hence, management of hyperuricemia may prevent the progression of renal disease, even in patients with normal renal function, suggesting that early treatment with allopurinol should be an important part of the management of chronic kidney disease (CKD) patients. Long-term follow-up studies are warranted to identify the benefits of uric acid management on renal function and hypertension.
Kanbay
Mehmet
M
35. Sokak, 81/5, Bahcelievler, Ankara, 06490, Turkey. drkanbay@yahoo.com
Ozkara
Adem
A
Selcoki
Yusuf
Y
Isik
Bunyamin
B
Turgut
Faruk
F
Bavbek
Nuket
N
Uz
Ebru
E
Akcay
Ali
A
Yigitoglu
Ramazan
R
Covic
Adrian
A
D000368:Aged; D000493:Allopurinol / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D033461:Hyperuricemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011507:Proteinuria / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000493:Allopurinol; D003404:Creatinine
J Am Soc Nephrol. 2005 Jul;16(7):1909-19
15843466
Hypertension. 2000 Mar;35(3):746-51
10720589
Nephrol Dial Transplant. 2006 Feb;21(2):260-3
16326746
J Hum Hypertens. 1996 Oct;10(10):683-9
9004095
Circ J. 2005 Aug;69(8):928-33
16041161
Nature. 2006 Mar 9;440(7081):237-41
16407889
Am J Kidney Dis. 2004 Oct;44(4):642-50
15384015
J Clin Endocrinol Metab. 1994 Jan;78(1):25-9
8288709
Kidney Int. 2005 Jan;67(1):237-47
15610247
Hypertension. 2001 Nov;38(5):1101-6
11711505
Hypertension. 2003 Jun;41(6):1183-90
12707287
Circulation. 2002 Jul 9;106(2):221-6
12105162
Am J Kidney Dis. 1999 Feb;33(2):225-34
10023633
Am J Epidemiol. 1985 Jan;121(1):11-8
3964986
Nephrol Dial Transplant. 2006 Nov;21(11):3046-7
16963481
J Hypertens. 2000 Jan;18(1):97-101
10678549
Am J Physiol Renal Physiol. 2006 Mar;290(3):F625-31
16234313
Am J Physiol Renal Physiol. 2001 Jul;281(1):F1-11
11399641
Ann Intern Med. 2005 Oct 4;143(7):499-516
16204163
Kidney Int. 2005 May;67(5):1739-42
15840020
Nature. 2003 Oct 2;425(6957):516-21
14520412
Mol Cell. 1998 Aug;2(2):275-81
9734366
Hypertension. 2003 Jun;41(6):1287-93
12743010
Diabetes Care. 1996 May;19(5):414-8
8732701
Am J Kidney Dis. 2006 Jan;47(1):51-9
16377385
Hypertens Res. 2001 Nov;24(6):691-7
11768729
Stroke. 1998 Mar;29(3):635-9
9506605
J Am Soc Nephrol. 2002 Dec;13(12):2888-97
12444207
Am J Nephrol. 2003 Jan-Feb;23(1):2-7
12373074
Metabolism. 2006 Oct;55(10):1293-301
16979398
Kidney Int Suppl. 2005 Dec;(99):S82-6
16336583
N Engl J Med. 1966 Sep 1;275(9):457-64
5917940
J Biol Chem. 1991 May 5;266(13):8604-8
2022672